TRADE POLICY | 2026-07-03
Section 232 Pharmaceutical Tariffs Take Effect July 31, 2026
A presidential proclamation under Section 232 imposes a 100 percent tariff on many imported branded and patented pharmaceuticals and their active ingredients, with the first companies affected on July 31, 2026 and all others on September 29, 2026 — a change that reaches deep into California life sciences, hospitals, and drug supply chains.
By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published
On April 2, 2026, the President signed a proclamation under Section 232 of the Trade Expansion Act of 1962 that will reshape how branded medicines reach American patients. The proclamation imposes a tariff of 100 percent on many imported patented and branded pharmaceutical products, as well as on the active pharmaceutical ingredients used to make them. The first companies affected are hit on July 31, 2026, with all others following on September 29, 2026.
Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.
Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301